Countries where authors publish in Current Pharmaceutical Biotechnology
Since Specialization
Citations
This map shows the geographic impact of research published in Current Pharmaceutical Biotechnology. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Current Pharmaceutical Biotechnology with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Current Pharmaceutical Biotechnology more than expected).
Fields of papers published in Current Pharmaceutical Biotechnology
This network shows the impact of papers published in Current Pharmaceutical Biotechnology. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Current Pharmaceutical Biotechnology.
About Current Pharmaceutical Biotechnology
The 2.8k papers published in Current Pharmaceutical Biotechnology in the last decades have received a total of 58.8k indexed citations . Papers published in Current Pharmaceutical Biotechnology usually cover Pharmaceutical Science (108 papers), Molecular Biology (1.1k papers) and Biotechnology (137 papers) specifically the topics of RNA Interference and Gene Delivery (149 papers), Monoclonal and Polyclonal Antibodies Research (125 papers), Nanoparticle-Based Drug Delivery (103 papers), Advanced biosensing and bioanalysis techniques (79 papers), Computational Drug Discovery Methods (76 papers), Protein purification and stability (68 papers), Advanced Drug Delivery Systems (68 papers) and Essential Oils and Antimicrobial Activity (66 papers). The most active scholars publishing in Current Pharmaceutical Biotechnology are Undurti N. Das, Prashant Bisen, David M. Dohan Ehrenfest, John S. Philo, Tsutomu Arakawa, Gabriele Bierbaum, Hans‐Georg Sahl, Janice M. Reichert, William C. Campbell and Αndroulla N. Miliotou.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.